ArticlebioRxiv : the preprint server for biology2024
A Surface-based deep learning approach for cortical shape analysis.
Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in deep learning hold promise for predicting clinical factors from human brain images. In this study, we applied a spherical harmonics-based convolutional neural network approach (SPHARM-Net) to MRI-derived brain shape metrics to predict age, sex, and Alzheimer's disease (AD) diagnosis. MRI-derived brain features included vertex-wise cortical curvature, convexity, thickness, and surface area. SPHARM-Net performs convolutions using the spherical harmonic transforms, eliminating the need to explicitly define neighborhood size, and achieving rotational equivariance. Sex classification and age regression were carried out in a large sample of healthy adults (UK Biobank; N=32,979), and AD classification performance was tested in a large, publicly available sample (ADNI; N=1,213). SPHARM-Net showed strong performance for sex classification (accuracy=0.91; balanced accuracy= 0.91; AUC=0.97), and age regression (average absolute error=2.97 years; R-squared=0.77; Pearson's coefficient=0.9). AD classification also performed well (accuracy=0.86; balanced accuracy=0.83; AUC=0.9). Our experiments demonstrate promising preliminary performance using the SPHARM-Net for two widely studied benchmarking tasks and for AD classification. Future work will include comparisons of shape-based methods and extending these analysis to more challenging tasks such as mood disorder classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.